Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

BACKGROUND: The 3-weekly combination of trastuzumab and paclitaxel has been approved for the treatment of advanced breast cancer based on a large pivotal study. However, mono and combination chemotherapy trials suggest that weekly paclitaxel has a better therapeutic index, especially in the palliati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: John, Matthias, Hinke, Axel, Stauch, Martina, Wolf, Heiner, Mohr, Benno, Hindenburg, Hans-Joachim, Papke, Jens, Schlosser, Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3443018/
https://ncbi.nlm.nih.gov/pubmed/22559145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados